Results 201 to 210 of about 1,341,685 (356)

Comparison of Major Protein-Source Foods and Other Food Groups in Meat-Eaters and Non-Meat-Eaters in the EPIC-Oxford Cohort [PDF]

, 2019
Keren Papier, Tammy Y. N. Tong, Paul N. Appleby, Kathryn E. Bradbury, Georgina K. Fensom, Anika Knüppel, Aurora Perez‐Cornago, Julie A. Schmidt, Ruth C. Travis, Timothy J. Key   +9 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Patterns and influencing factors of intestinal microbiota from different groupers. [PDF]

Anim Microbiome
Song W, Chen C, Du X, Zhang R, Zhao J.
europepmc   +1 more source

A Secure and Lightweight Group Mobility Authentication Scheme for 6LoWPAN Networks [PDF]

Fatma Foad Ashrif, Elankovan Sundararajan, Mohammad Kamrul Hasan, Rami Ahmad   +3 more
openalex   +1 more source

A Heat-Map-Based Algorithm for Recognizing Group Activities in Videos [PDF]

, 2013
Weiyao Lin, Hang Chu, Jianxin Wu, Bin Sheng, Zhenzhong Chen   +4 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

Corrigendum to 'Characterization and antibody preparation of the gene products of grouper iridovirus ORF120L' [Virus Research 360 (2025) 199625]. [PDF]

Virus Res
Cheng CF, Chuang HC, Lai YS.
europepmc   +1 more source

On the automorphism group of the superextension of a semigroup

, 2017
Volodymyr Gavrylkiv
openalex   +1 more source

Nonhierarchical clustering technique (GROUPER) [PDF]

Behavior Research Methods & Instrumentation, 1974
Ronald G. Sherwin, Nien-ling Wayman
openaire   +1 more source

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source